Quest Diagnostics (DGX) Price to Earnings (2009 - 2026)

Quest Diagnostics has disclosed Price to Earnings across 18 years of filings, most recently posting 72.2 for Q2 2026.

• In Q2 2026, Price to Earnings rose 3.16% year-over-year to 72.2; the TTM figure through Jun 2026 stood at 21.58 (up 3.78% YoY), while the FY2025 annual figure was 18.99, up 2.31% from the prior year.
• Price to Earnings came in at 72.2 for Q2 2026 at Quest Diagnostics, down from 83.44 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 154.12 in Q4 2022 to a low of 46.97 in Q1 2022.
• Average Price to Earnings over 5 years is 75.07, with a median of 73.21 recorded in 2024.
• Year-over-year, Price to Earnings surged 189.34% in 2022 and slumped 49.72% in 2023.
• Over 5 years, Price to Earnings stood at 154.12 in 2022, then tumbled by 49.72% to 77.48 in 2023, then retreated by 6.46% to 72.48 in 2024, then climbed by 5.64% to 76.57 in 2025, then slipped by 5.7% to 72.2 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 72.2 in Q2 2026, 83.44 in Q1 2026, and 76.57 in Q4 2025.